Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2026-03-03 @ 12:36 AM
Study NCT ID:
NCT01344369
Status:
COMPLETED
Last Update Posted:
2011-05-30
First Post:
2011-04-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions
Sponsor:
Teva Pharmaceuticals USA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
10816221
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Associate Director, Biopharmaceutics
Old Organization:
Teva Pharmaceuticals, USA